SCHEMBL22876983

SCHEMBL22876983

CCc1ccc(CN2CCC(CN=O)CC2)cn1

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.42
▸ HRH3 Q9Y5N1 4/20 0.40
▸ CYP2D6 P10635 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ IL6 P05231 1/20 0.38
▸ TLR7 Q9NYK1 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ CACNA1I Q9P0X4 1/20 0.38
▸ PRMT5 O14744 1/20 0.37
▸ WDR77 Q9BQA1 1/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ ATM Q13315 1/20 0.37
▸ CCR3 P51677 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21414380 0.84 KMT2A (0.44) KMT2AHRH3TLR7KCNH2CACNA1I
SCHEMBL21414344 0.83 HRH3 (0.46) KMT2AHRH3CYP2D6CYP1A2MEN1
SCHEMBL21414342 0.80 RAB9A (0.55) KMT2AHRH3CYP2D6CYP1A2MEN1
SCHEMBL20356732 0.77 HRH3 (0.62) KMT2AHRH3CYP2D6CYP1A2MEN1
SCHEMBL20443001 0.76 ALDH1A1 (0.54) KMT2AHRH3CYP2D6CYP1A2PRMT5
SCHEMBL25728960 0.76 CYP1A2 (0.63) KMT2AHRH3CYP2D6CYP1A2MEN1
SCHEMBL10289221 0.75 LMNA (0.51) KMT2AHRH3CYP2D6CYP1A2MEN1
SCHEMBL12651283 0.74 HRH3 (0.53) KMT2AHRH3CYP2D6CYP1A2MEN1
SCHEMBL21414343 0.74 CXCR4 (0.49) KMT2AHRH3CYP2D6CYP1A2MEN1
SCHEMBL12829333 0.72 MEN1 (0.69) KMT2AHRH3CYP2D6MEN1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3546458-B1 ((PYRIDIN-2-YL)-AMINO)PYRIDO[3,4-D]PYRIMIDINE AND ((PYRIDAZIN-3-YL)-AMINO)PYRIDO[3,4-D]PYRIMIDINE DERIVATIVES AS CDK4/6 INHIBITORS FOR TREATING E.G. RHEUMATOID ARTHRITIS, ARTERIOSCLEROSIS, PULMONARY FIBROSIS, CEREBRAL INFARCTION OR CANCER TEIJIN PHARMA LTD (JP) 2021-01-06 — — EP disclosed
Send feedback